Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3742579015 | Product containing only rotigotine in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3742580017 | Rotigotine only product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5580341000241115 | produit contenant seulement de la rotigotine sous forme transdermique | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only rotigotine in transdermal dose form (medicinal product form) | Is a | Product containing only rotigotine (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only rotigotine in transdermal dose form (medicinal product form) | Is a | Rotigotine-containing product in transdermal dose form | true | Inferred relationship | Some | ||
| Product containing only rotigotine in transdermal dose form (medicinal product form) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing only rotigotine in transdermal dose form (medicinal product form) | Has manufactured dose form | Transdermal dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only rotigotine in transdermal dose form (medicinal product form) | Has active ingredient | Rotigotine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only rotigotine in transdermal dose form (medicinal product form) | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rotigotine 83.333 microgram/hour prolonged-release transdermal patch | Is a | True | Product containing only rotigotine in transdermal dose form (medicinal product form) | Inferred relationship | Some | |
| Rotigotine 166.667 microgram/hour prolonged-release transdermal patch | Is a | True | Product containing only rotigotine in transdermal dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | True | Product containing only rotigotine in transdermal dose form (medicinal product form) | Inferred relationship | Some | |
| Rotigotine 125 microgram/hour prolonged-release transdermal patch | Is a | True | Product containing only rotigotine in transdermal dose form (medicinal product form) | Inferred relationship | Some | |
| Rotigotine 41.667 microgram/hour prolonged-release transdermal patch | Is a | True | Product containing only rotigotine in transdermal dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR